Covid-19 Updates | Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030
- Created by: Stella01wilson
- Created on: 21-07-21 12:14
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production.
Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:
· A detailed review of the overall landscape of companies, offering contract services for the manufacturing of antibodies.
· A competitiveness analysis of key players engaged in this domain, featuring an assessment based on their supplier strength and service strength.
· A benchmark analysis, highlighting the key focus areas of small, mid-sized and large companies, comparing their existing capabilities within and beyond their respective (geography-based) peer groups.
· An analysis of the various partnerships pertaining to contract manufacturing of antibodies, which have been established since 2013.
· An analysis of the various expansion initiatives undertaken by service providers, in order to augment their respective antibody manufacturing capabilities, over the period 2017-2019 (till October).
· An estimate of the overall, installed capacity for manufacturing antibodies based on data…
Comments
No comments have yet been made